Abstract
Temporal arteritis is the most common form of systemic vasculitis affecting elderly persons. The disease is considered a medical emergency, with potentially severe ophthalmic complications such as rapidly progressive irreversible visual loss. A prompt diagnosis and an immediate pharmacologic treatment are mandatory in order to prevent these complications. At present temporal artery biopsy is considered the diagnostic “gold standard” but new evidences support the role of ultrasonography as a non-invasive approach for the diagnosis of the disease. Recent advances in technologic equipment, together with skilled operators, will contribute to support the role of this approach in the diagnosis, follow-up and prevention of subsequent flares of the disease after treatment withdrawal. Further studies to assess the test performance in these settings are warranted.
Similar content being viewed by others
Bibliografia
Horton BT, Magath BT, Brown GE (1937) Arteritis of temporal vessels: report of 7 cases. Proc Staff Meet Mayo Clin 12:548–553
Jennings GH (1938) Arteritis of the temporal vessels. Lancet 1:424
Smith CA, Fidler WJ, Pinals RS (1983) The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum 26:1214–1219
Boesen P, Sørensen SF (1987) Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982–1985. Arthritis Rheum 30:294–299
Salvarani C, Gabriel SE, O’Fallon WM, Hunder GG (1995) The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 123:192–194
Kobayashi S, Yano T, Matsumoto Y et al (2003) Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum 49:594–598
Salvarani C, Macchioni P, Zizzi F et al (1991) Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 34:351–356
Salvarani C, Crowson CS, O’-Fallon WM et al (2004) Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fiftyyear period. Arthritis Rheum 51:264–268
Hunder GG, Bloch DA, Michel BA et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128
Devauchelle-Pensec V, Jousse S, Destombe C, Saraux A (2008) Epidemiology, imaging and treatment of giant cell arteritis. Joint Bone Spine 75:267–272
Hu Z, Yang Q, Zeng S et al (2002) Giant cell arteritis in China: a prospective investigation. Angiology 53:457–463
Wang X, Hu ZP, Lu W et al (2008) Giant cell arteritis. Rheumatol Int 29:1–7
Rahman W, Rahman FZ (2005) Giant cell (temporal) arteritis: an overview and update. Surv Ophthalmol 50:415–428
Weyand CM, Bartley GB (1997) Giant cell arteritis: new concepts in pathogenesis and implications for management. Am J Ophthalmol 123:392–395
Navarro M, Cervera R, Font J et al (1997) Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus 6:521–526
Gonzalez-Gay MA (2005) The diagnosis and management of patients with giant cell arteritis. J Rheumatol 32:1186–1188
Narváez J, Bernad B, Roig-Vilaseca D et al (2007) Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum 37:13–19
Hayreh SS, Podhajsky PA, Raman R, Zimmerman B (1997) Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 123:285–296
Bhatti MT, Goldstein MH (2001) Facial nerve injury following superficial temporal artery biopsy. Dermatol Surg 27:15–17
Mizen TR (1991) Giant cell arteritis: diagnostic and therapeutic considerations. Ophthalmol Clin North Am 4:547–556
Kelley JS (1978) Doppler ultrasound flow detector used in temporal artery biopsy. Arch Ophthalmol 96:845–846
Dany F, Liozon F, Chaumont P et al (1989) Sensibilité et specificité du Doppler temporal dans la maladie de Horton. J Mal Vasc 14[Suppl. C]:104–108
Vinckier L, Hatron PY, Gadenne C et al (1989) Intérêt du Doppler arteriel dans la maladie de Horton. J Mal Vasc 14[Suppl. C]:116–122
Puéchal X, Chauveau M, Menkès CJ (1995) Temporal Doppler-flow studies for suspected giant-cell arteritis. Lancet 345:1437–1438
Schmidt WA, Kraft HE, Vorpahl K et al (1997) Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 337:1336–1342
Salvarani C, Silingardi M, Ghirarduzzi A et al (2002) Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? Ann Intern Med 137:232–238
Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP (2005) Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med 142:359–369
Karahaliou M, Vaiopoulos G, Papaspyrou S et al (2006) Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther 8:R116
Bley TA, Wieben O, Uhl M et al (2005) High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. AJR Am J Roentgenol 184:283–287
Blockmans D, de Ceuninck L, Vanderschueren S et al (2006) Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 55:131–137
Author information
Authors and Affiliations
About this article
Cite this article
Sinigaglia, L., Casari, S. & Di Luca, G. Arterite di Horton: è sempre necessaria la biopsia dell’arteria temporale?. Arch Ortop Reumatol 121, 23–25 (2010). https://doi.org/10.1007/s10261-010-0011-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10261-010-0011-1